SEC 13F Intelligence

Ghost Tree Capital, LLC / AKRO

Ghost Tree Capital, LLC’s Akero Therapeutics Inc Com Position

Does Ghost Tree Capital, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 115.0K shares worth $6M in Q3 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$6M
Q3 2023
Shares
115.0K
% of Portfolio
+1.91%
Quarters Held
4
position exited

Position History AKRO

Reported value by quarter
Q4 ’22: $5MQ4 ’22Q1 ’23: $11MQ1 ’23Q2 ’23: $17MQ2 ’23Q3 ’23: $6MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023115.0K$6M+1.91%
Q2 2023360.0K$17M+5.55%
Q1 2023275.0K$11M+3.11%
Q4 202285.0K$5M+1.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of AKRO.